Cosentyx unoready 300 MG pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FBXBG
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,559
Award facts
- Contract value 100% obligated
- $21,558.58 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $21,558.58 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Cosentyx (secukinumab) 300 mg pen injections in 2 mL formulations. This is a non-set-aside, competitively awarded contract with a completion deadline of September 30, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that enables the contractor to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, regularly fulfills delivery orders through the DLA Medical Supply Chain for brand-name medications, generics, vaccines, and specialized medical supplies across multiple therapeutic domains. The company's role in the DLA Pharmaceutical Prime Vendor Global Program reflects its capability to meet federal procurement requirements through open competition and supports military healthcare systems, including the Defense Health Agency and U.S. Coast Guard. This specific award for Cosentyx, a specialty immunosuppressant medication, demonstrates the contractor's continued role in supplying specialized pharmaceutical products to support military and veteran healthcare needs.
Quick answers
Who was awarded contract SPE2DB25FBXBG?
SPE2DB25FBXBG was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 29, 2025.
How much is contract SPE2DB25FBXBG worth?
The government has obligated $21,559 on SPE2DB25FBXBG.
Is contract SPE2DB25FBXBG an order under another contract?
Yes. SPE2DB25FBXBG is a delivery order under SPE2DB24D2012, an indefinite delivery contract.
Was contract SPE2DB25FBXBG competed?
The extent of competition for SPE2DB25FBXBG was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award